Headquarters
8048 DANCING WIND LN APT 1304, NAPLES, FL 34119-3394, US
NAPLES, FL, US
ALTERON THERAPEUTICS INC.
From the company
Alteron Therapeutics develops first-in-class TDP-43 inhibitors, the ALTA drug series, to find cures for neurodegeneration and cystic fibrosis. The company targets TDP-43 toxicity, which contributes to ALS, Alzheimer's disease, and frontotemporal lobar degeneration. Its leading drug candidate is orally bioavailable, crosses the blood-brain barrier, and shows potential to reverse ALS symptoms.
Products & services offered
Classifications
- Ownership classifications (1)
- Asian-Pacific American Owned
Facilities
Send your requirements
Quantities, certifications, and timing.